Medical News on Cancer
New Intriguing Knowledge On Blood Haemoglobin Published
Sep 04, 2012
Scientists at the research centre MEMBRANES at Aarhus University, Denmark, have completed an old puzzle, which has been regarded as impossible to complete since the 60s. The challenge was to solve the structure of the protecting protein complex that forms when haemoglobin is released from red cells and becomes toxic... Read More
Xtandi (Enzalutamide) Approved For Late Stage Prostate Cancer, FDA
Sep 03, 2012
Xtandi (enzalutamide) has been approved for men with metastatic castration-resistant prostate cancer that has recurred or spread, regardless of whether patients received medical or surgical therapy to reduce testosterone levels, the US Food and Drug Administration (FDA) announced. Enzalutamide has been approved to be administered alongside docetaxel, another cancer medication... Read More
Combined Chemotherapy Effective For Immunodeficient Patients With Secondary Lung Disease
Sep 03, 2012
A team of researchers at the Medical College of Wisconsin and Children's Hospital of Wisconsin Research Institute defined a new treatment for a potentially fatal lung disease in patients with a primary immunodeficiency known as common variable immunodeficiency (CVID).The findings are published in the Journal of Clinical Immunology... Read More
A Possible Therapy For Tamoxifen-Resistant Breast Cancer Identified
Sep 03, 2012
A study by researchers at the Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James) has discovered how tamoxifen-resistant breast-cancer cells grow and proliferate. It also suggests that an experimental agent might offer a novel targeted therapy for tamoxifen-resistant breast cancer... Read More
Diverse Metabolic Roles Revealed For PML Tumor Suppressor Gene
Sep 03, 2012
Two papers led by scientific teams from the Cancer Genetics Program at Beth Israel Deaconess Medical Center (BIDMC) shed new light on the genetic mechanisms underlying cellular energy and metabolism and, at the same time, highlight both the challenges and opportunities of genetic approaches to cancer treatment... Read More
Microcirculation Of Malaria-Infected Red Blood Cells Impeded By Protein
Sep 03, 2012
When the parasite responsible for malaria infects human red blood cells, it launches a 48-hour remodeling of the host cells. During the first 24 hours of this cycle, a protein called RESA undertakes the first step of renovation: enhancing the stiffness of the cell membranes... Read More
Mechanism Discovered That Leads From Trichomoniasis To Prostate Cancer
Sep 01, 2012
Researchers have identified a way in which men can develop prostate cancer after contracting trichomoniasis, a curable but often overlooked sexually transmitted disease. Previous studies have teased out a casual, epidemiological correlation between the two diseases, but this latest study suggests a more tangible biological mechanism... Read More
Quest Diagnostics Launches Molecular Cervical Cancer Test Based On National Institutes Of Health's TERC Gene Marker
Sep 01, 2012
May enhance evaluation of cancer risk in the up to 1... Read More
2 Chemo Drugs For Breast Cancer May Cause Heart Problems
Sep 01, 2012
Women who have breast cancer and are treated with two chemotherapy drugs may experience more cardiac problems like heart failure than shown in previous studies, according to a new Cancer Research Network study by Group Health researchers and others in the Journal of the National Cancer Institute... Read More
New Cancer Drug Efficiently Targets Breast, Lung And Colon Cancer; Clinical Trials Could Start Within 2 Years
Aug 31, 2012
Legend has it that Ralph Waldo Emerson once said, "Build a better mousetrap, and the world will beat a path to your door." University of Missouri researchers are doing just that, but instead of building mousetraps, the scientists are targeting cancer drugs... Read More
Previous Page Next Page